Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rick L Tarleton

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Plos Neglected Tropical Diseases|October 31, 2022
Prophylactic low-dose, bi-weekly benznidazole treatment fails to prevent Trypanosoma cruzi infection in dogs under intense transmission pressureJuan M Bustamante, Angel M Padilla, Brooke White, et al.
Plos Neglected Tropical Diseases|December 19, 2013
Polyfunctional T cell responses in children in early stages of chronic Trypanosoma cruzi infection contrast with monofunctional responses of long-term infected adultsMaría C Albareda, Ana M De Rissio, Gonzalo Tomas, et al.
Microbes and Infection|February 4, 2010
Trypanosoma cruzi-specific immune responses in subjects from endemic areas of Chagas disease of ArgentinaGabriela C Olivera, Maria C Albareda, Maria G Alvarez, et al.
The Journal of Antimicrobial Chemotherapy|March 11, 2021
Reduced Trypanosoma cruzi-specific humoral response and enhanced T cell immunity after treatment interruption with benznidazole in chronic Chagas diseaseMelisa D Castro Eiro, María A Natale, María G Alvarez, et al.
Plos Pathogens|August 2, 2006
CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopesDiana L Martin, D Brent Weatherly, Susana A Laucella, et al.
Frontiers in Immunology|October 3, 2017
The Significance of Discordant Serology in Chagas Disease: Enhanced T-Cell Immunity to <i>Trypanosoma cruzi</i> in Serodiscordant SubjectsMelisa D Castro Eiro, María G Alvarez, Gretchen Cooley, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2020
New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: Clinical, Parasitological, and Serological Assessment after Three Years of Follow-UpMaría Gabriela Álvarez, Juan Carlos Ramírez, Graciela Bertocchi, et al.
Frontiers in Immunology|October 2, 2018
Distinct Treatment Outcomes of Antiparasitic Therapy in <i>Trypanosoma cruzi</i>-Infected Children Is Associated With Early Changes in Cytokines, Chemokines, and T-Cell PhenotypesMaría C Albareda, María A Natale, Ana M De Rissio, et al.
Bioorganic & Medicinal Chemistry|April 2, 2010
Trypanoside, anti-tuberculosis, leishmanicidal, and cytotoxic activities of tetrahydrobenzothienopyrimidinesJosé C Aponte, Abraham J Vaisberg, Denis Castillo, et al.
Nature Microbiology|September 6, 2022
Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primatesAngel M Padilla, Wei Wang, Tsutomu Akama, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Plos Neglected Tropical Diseases|October 31, 2022
Prophylactic low-dose, bi-weekly benznidazole treatment fails to prevent Trypanosoma cruzi infection in dogs under intense transmission pressureJuan M Bustamante, Angel M Padilla, Brooke White, et al.
Plos Neglected Tropical Diseases|December 19, 2013
Polyfunctional T cell responses in children in early stages of chronic Trypanosoma cruzi infection contrast with monofunctional responses of long-term infected adultsMaría C Albareda, Ana M De Rissio, Gonzalo Tomas, et al.
Microbes and Infection|February 4, 2010
Trypanosoma cruzi-specific immune responses in subjects from endemic areas of Chagas disease of ArgentinaGabriela C Olivera, Maria C Albareda, Maria G Alvarez, et al.
The Journal of Antimicrobial Chemotherapy|March 11, 2021
Reduced Trypanosoma cruzi-specific humoral response and enhanced T cell immunity after treatment interruption with benznidazole in chronic Chagas diseaseMelisa D Castro Eiro, María A Natale, María G Alvarez, et al.
Plos Pathogens|August 2, 2006
CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopesDiana L Martin, D Brent Weatherly, Susana A Laucella, et al.
Frontiers in Immunology|October 3, 2017
The Significance of Discordant Serology in Chagas Disease: Enhanced T-Cell Immunity to <i>Trypanosoma cruzi</i> in Serodiscordant SubjectsMelisa D Castro Eiro, María G Alvarez, Gretchen Cooley, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2020
New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: Clinical, Parasitological, and Serological Assessment after Three Years of Follow-UpMaría Gabriela Álvarez, Juan Carlos Ramírez, Graciela Bertocchi, et al.
Frontiers in Immunology|October 2, 2018
Distinct Treatment Outcomes of Antiparasitic Therapy in <i>Trypanosoma cruzi</i>-Infected Children Is Associated With Early Changes in Cytokines, Chemokines, and T-Cell PhenotypesMaría C Albareda, María A Natale, Ana M De Rissio, et al.
Bioorganic & Medicinal Chemistry|April 2, 2010
Trypanoside, anti-tuberculosis, leishmanicidal, and cytotoxic activities of tetrahydrobenzothienopyrimidinesJosé C Aponte, Abraham J Vaisberg, Denis Castillo, et al.
Nature Microbiology|September 6, 2022
Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primatesAngel M Padilla, Wei Wang, Tsutomu Akama, et al.
Pageof 10